Page 837 - Clinical Immunology_ Principles and Practice ( PDFDrive )
P. 837

59









                                                                     Large-Vessel Vasculitides



                                                                                               Cornelia M. Weyand








           Most tissues have compensatory mechanisms that allow them   monitoring. Excellent progress has been made in unraveling the
           to sustain the damaging effects of acute and chronic inflammation,   pathogenesis of GCA, and this will inevitably lead to improve-
           but medium and large arteries are organs without redundancy   ments in diagnosis, long-term management, and broadening of
           and limited regenerative capacity. Life is unsustainable unless   the therapeutic armamentarium.
           the major arteries have uncompromised function. Accordingly,
           inflammatory damage to such arterial vessels leads to severe   EPIDEMIOLOGY
           clinical consequences, immediately posing a threat for the loss
           of function of vital organs. When affected by inflammation, the   GCA may be a very old disease, as suggested by historic evidence
           aorta and its branches have two possible response patterns: (i)   that more than 1000 years ago removal of the temporal artery
           Inflammatory destruction of the vessel wall leads to dilatation,   was recommended by a physician in Baghdad. In 1932, Horton
           aneurysm formation, and rupture. Alternatively, the wall layers   et al. at the Mayo Clinic in Minnesota recognized that GCA was
           dissect. (ii) The inflammation initiates a maladaptive response   an inflammatory vasculopathy when they found dense inflam-
           to injury, resulting in luminal occlusion, disruption of blood   mation in the temporal arteries of two patients who were systemi-
           supply, and ischemic damage of dependent organ structures.  cally ill and had severe headaches. The first reports of TA, or
             In contrast to other vasculopathies, especially those related   “pulseless disease,” in young women surfaced in Japan in the
           to atherosclerosis, vasculitides of the larger blood vessels are   nineteenth century. The syndrome was named after Dr. Takayasu,
           almost always associated with a syndrome of intense systemic   an ophthalmologist, who, in 1905, described peculiar optic fundus
                      1
           inflammation.  Recent evidence has challenged the traditional   abnormalities caused by ischemia-driven collateral formation.
                                                                                                                   3,4
           view that systemic inflammation represents a spillover of inflam-  The strongest risk factor for GCA, TA, and PMR is age.
           matory mediators from the vasculitic lesions. Instead, systemic   GCA and PMR are essentially absent in individuals <50 years
           activation of the innate immune system appears to be a pinnacle   of age, and their incidence climbs continuously during the seventh
           event that initiates the processes leading to vessel wall inflam-  and eighth decades of life. TA is almost exclusively diagnosed
           mation. The coincidence of malaise, fever, wasting, and myalgias,   in individuals <40 years of age, with peak incidence during the
           with signs of ischemia caused by vascular failure, remains a critical   second and third decades of life. Women are affected more often
           clue for the physician when diagnosing and treating large-vessel   by all three syndromes compared with men, with a 2 : 1 ratio in
           vasculitides (LVVs).                                   PMR and GCA and a 9 : 1 ratio in TA. 3,5
             The two major forms of LVVs are giant-cell arteritis (GCA)   Marked geographical variations in the incidence and prevalence
           and Takayasu arteritis (TA). In addition, aortitis can infrequently   of GCA, TA, and PMR have given rise to speculations about
           be seen in other diseases, such as infections, connective tissue   environmental exposures as key factors in disease pathogenesis.
           diseases, sarcoidosis, and inflammatory bowel disease (IBD), and   GCA is the most frequent vasculitis in the Western world, with
           occasionally is diagnosed as an idiopathic syndrome. Polymyalgia   yearly incidence rates reaching 10–20 cases per 100 000 persons
                                                                               3
           rheumatica (PMR) is a condition closely related to GCA; it occurs   >50 years of age.  In general, PMR is diagnosed three- to fourfold
           in the same patient population and often precedes or follows   more frequently, with a prevalence of up to 1 case per 133
                                   2
                                                                                    2
           the clinical diagnosis of GCA.  Patients with PMR do not have   individuals >50 of age.  Iceland, Norway, Sweden, and Denmark
           typical vascular lesions; consequently, PMR is not classified as   are high-risk areas; higher incidence rates are also seen in
           a  vasculitis.  However,  patients  with  PMR  do  have  a  systemic   Scandinavian immigrant populations in the United States. The
           inflammatory syndrome indistinguishable from GCA, and about   risk is significantly lower in Hispanics and African Americans.
           10% of patients with PMR eventually progress to full-blown   Although TA can afflict all races, a predilection exists for individu-
           vasculitis. Similarities in the vascular lesions of GCA and TA   als of Asian and Central and South American origins. Japan,
           have been interpreted as revealing parallels in immunopatho-  Thailand, India, Turkey, and nations in Central and South
           genesis.  Whether similarities in histomorphology and tissue   Americas are considered high-incidence regions. TA is a rare
           targeting reflect similarities in underlying molecular defects   disease with an annual incidence of 1–2 cases/million. The typical
           remains unclear. Whether the systemic inflammatory reactions   patient is a female in her 20s to 30s. In middle-aged men and
           accompanying GCA, TA, and PMR have disease-specific elements   women, it can be challenging to differentiate TA from rapidly
           also remains unanswered, but this has opened the possibility of   progressing atherosclerotic disease, especially as both disease
           developing  biomarkers  that  are  urgently  needed  for  clinical   processes may coexist. 6

                                                                                                                809
   832   833   834   835   836   837   838   839   840   841   842